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Abstract
Patients with systemic autoimmune diseases usually produce
high levels of antibodies to self-antigens (autoantigens). The
repertoire of common autoantigens is remarkably limited, yet no
readily understandable shared thread links these apparently
diverse proteins. Using computer prediction algorithms, we have
found that most nuclear systemic autoantigens are predicted to
contain long regions of extreme structural disorder. Such
disordered regions would generally make poor B cell epitopes
and are predicted to be under-represented as potential T cell
epitopes. Consideration of the potential role of protein disorder
may give novel insights into the possible role of molecular
mimicry in the pathogenesis of autoimmunity. The recognition of
extreme autoantigen protein disorder has led us to an explicit
model of epitope spreading that explains many of the
paradoxical aspects of autoimmunity – in particular, the difficulty
in identifying autoantigen-specific helper T cells that might
collaborate with the B cells activated in systemic autoimmunity.
The model also explains the experimentally observed breakdown
of major histocompatibility complex (MHC) class specificity in
peptides associated with the MHC II proteins of activated
autoimmune B cells, and sheds light on the selection of
particular T cell epitopes in autoimmunity. Finally, the model
helps to rationalize the relative rarity of clinically significant
autoimmunity despite the prevalence of low specificity/low
avidity autoantibodies in normal individuals.
Introduction
Why some proteins become autoantigens is one of the mys-
teries of immunology. Indeed, as Paul Plotz put it in a recent
review, "The repertoire of target autoantigens is a
Wunderkammer – a collection of curiosities – of molecules
with no obvious linking principle" [1]. Most immunologists
believe, probably with good reason, that making real progress
in understanding and treating autoimmune diseases depends
on solving this mystery.
While a single property might explain why these few proteins
become autoantigens, it seems more likely that a combination
of factors unites these proteins. Plotz divides such factors into
four groups: structural properties, catabolism and fate after
cell death, concentration and the microenvironment, and
immunological and inflammatory properties. This paper will pri-
marily deal with the first of Plotz's factors, the structural prop-
erties of autoantigens. Among the structural properties he lists
are, citing the work of Dohlman and colleagues [2,3]: a highly
charged surface, repetitive surface elements, bound nucleic
acid, and the presence of a coiled coil. In this paper, we pro-
vide computational evidence that the first three of these prop-
erties can be understood as arising from the fact that most
nuclear systemic autoantigens are extremely disordered pro-
teins, and suggest that the fourth property, the presence of a
coiled coil, occurs far less frequently than does disorder. We
also show that several of the other factors mentioned by Plotz
that may influence the selection of autoantigens also fit nicely
into the picture of nuclear systemic autoantigens as extremely
disordered proteins. We will argue that disordered proteins
are apt to be poor activators of B cells for multiple reasons,
and hence that B cells targeted to extremely disorderedR1360
EBV = Epstein-Barr virus; hNNuSP = human non-nuclear protein database; hNuSP = human nuclear protein database; hNuSysAAG = human nuclear 
systemic autoantigen database; hSP = human protein database; LDR = long disordered region; MHC = major histocompatibility complex; sIg = sur-
face Ig; SLE = systemic lupus erythematosus; snRNP = small nuclear ribonucleoprotein particle.
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R1361proteins are apt to escape immune deletion. Furthermore,
because extremely disordered proteins tend to be highly sen-
sitive to proteolysis and are predicted to have poor affinity for
major histocompatibility complex (MHC) II, these proteins are
also predicted to be under-represented as T cell epitopes. In
the Discussion we propose a model of how the pool of poten-
tially autoreactive B cells might subsequently become acti-
vated and lead to pathological consequences. This model
explicitly incorporates the fact that, in addition to being disor-
dered, the majority of nuclear systemic antigens are large com-
plexes of highly expressed structural macromolecules. The
model predicts that it should normally be difficult to identify T
cell populations that activate autoimmune B cells, and that
such activation might not require cell-to-cell contact between
B and T cells. Considerable evidence supports both of these
predictions. At the same time the model explains why, para-
doxically, some type of T cell-B cell contact is required in the
development of autoimmunity. Finally, the model provides
insights into why a specific T cell epitope is most commonly
associated with the SmB autoantigen in systemic lupus ery-
thematosus (SLE).
Defining protein disorder
The dominant picture of protein structure is that proteins fold
to a unique native state of lowest energy. There is now an
increased appreciation that the native state may not be a sin-
gle structure after all, but rather an ensemble of closely related
structures [4,5]. More recently has come an appreciation that
large regions of some proteins never fold at all, at least in the
absence of a binding partner. Regions that lack a fixed tertiary
structure as determined by weak or missing electron density in
a solved X-ray structure are identified as intrinsically disor-
dered. In what follows we shall use the terms 'disordered pro-
tein' and 'disordered region' somewhat interchangeably, while
recognizing that a 'disordered protein' can have regions of
extensive order. It is important to distinguish between a disor-
dered region that has a multiplicity of structures and a region
such as a loop that lacks alpha-helical or beta-sheet secondary
structure but may exist in a single structure.
While some aspects of protein disorder were appreciated
more than 50 years ago, we can thank Dunker and Obradovic
and their colleagues [6] for the current renaissance of interest
in the concept. A more rigorous discussion of the concept of
protein disorder is provided by Dunker et al. [6,7]. Excellent
recent reviews of protein disorder are provided by Uversky,
Gillespie and Fink [8], Fink [9], and Dyson and Wright [10],
who call such proteins 'natively unfolded' or 'intrinsically
unstructured'.
To develop software capable of predicting disordered regions,
Dunker, Obradovic and their colleagues analyzed experimen-
tally determined structures with disordered regions. They
developed a neural network model to predict disorder, trained
on regions of missing electron density in X-ray structures and
disordered regions in NMR structures. The current default
PONDR® predictor at the PONDR® web site [11] is VL-XT
[12-14]. It is a hybrid of three earlier predictors: VL1 used for
internal regions starting and ending 11 residues from the pro-
tein terminus; XN, an amino terminus predictor; and XC, a car-
boxyl terminus predictor. These predictors use a variety of
input attributes including coordination number, net charge,
hydropathy, and the presence of particular combinations of
amino acids. The false positive error rate, that is, the prediction
of disorder when a region is known to be ordered, of the VL-
XT predictor is estimated at 22% on a per residue basis. How-
ever, the predictor is far better at predicting long regions of
disorder, so that the false positive rate per residue drops to
1.7% per residue for consecutive regions of predicted disor-
der ≥40 residues. Further details on the training and accuracy
of the various PONDR® predictors are available on the
PONDR® web site.
Some additional PONDR® predictors are available at DisProt
[15], but these have not been used in this study.
PONDR® scores are characterized by a disorder index q,
which can range from 0 to 1, and are averaged over a window
of nine amino acids. The boundary between order and disorder
is conventionally set at q = 0.5. There is no clear criterion for
extreme disorder. In this paper we call a protein extremely dis-
ordered if it contains at least one long disordered region (LDR)
of 39 or more consecutive residues as predicted by PONDR®.
One should note that there are now several other web-based
predictors of protein disorder available based on different
algorithms and training sets. Examples are the DISOPRED
[16] and DISEMBL™ [17] predictors. DISEMBL™ also has a
complementary program GlobPlot™ [18] that focuses on pre-
dicting order. For the 19 LDRs presented in the figures, we
have also determined the degree of disorder using the two
DISEMBL™ and the DISOPRED disorder predictors. For all
the predictors, on average 57% to 70% of the residues in the
LDR predicted by PONDR® were confirmed to be disordered.
This agreement suggests that our conclusions about LDRs are
not strongly dependent on the particular disorder predictor
used.
Materials and methods
A database of 51 nuclear systemic autoantigens (hNuS-
ysAAG) was generated by SWISS-PROT text searches using
SRS [19] combined with literature searches for autoantigens
not yet annotated in SWISS-PROT. Keywords used in search-
ing SWISS-PROT included 'human (organism) and nuclear
and (autoantigen or autoimmune or antigen)' or 'human (organ-
ism) and nuclear and (scleroderma or sclerosis or lupus or
sjogren)'. In a few cases, for example, the histones, we added
widely recognized systemic nuclear autoantigens that were
not annotated as autoantigens in SWISS-PROT. Proteins
were removed from the initial search results for the following
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always clear how to classify the cellular location of a protein
that is largely located in the cytoplasm, such as Ro 52K, but
that shuttles to the nucleus – we generally assigned a nuclear
location to such proteins despite the degree of ambiguity
involved); not related to a systemic autoimmune disease; ori-
gin in a complex that was autoantigenic, but the protein was
not autoantigenic itself. Three additional control databases
were generated from SWISS-PROT: 10,962 human proteins
(hSP); 2,335 human nuclear proteins (hNuSP); and 8,627
human non-nuclear proteins (hNNuSP).
All the predictions of order/disorder presented in this paper
were made with the VL-XT predictor available at the PONDR®
web site [11]. The predictions of class II dependent T cell
epitopes were made with the ProPred predictor [20].
Results
Most nuclear systemic autoantigens are predicted to 
contain extremely disordered regions
PONDR® predictions for proteins vary from highly ordered to
almost completely disordered. In Fig. 1 we show typical pat-
terns for several human proteins, none of which are known
autoantigens, and all of which are in the Protein Data Bank
(PDB) [21], a structural database that is known to contain
largely ordered proteins. In contrast, the PONDR® plots of
several nuclear systemic autoantigens are shown in Fig. 2. It is
clear that the autoantigens shown in Fig. 2 are predicted to be
far more disordered than the non-autoantigenic proteins
shown in Fig. 1. To gain insight into the significance of the rela-
tionship between disorder and autoantigenicity, we performed
analyses of the various databases described earlier.
Of the 51 autoantigens in our hNuSysAAG database, 76% of
the proteins met our criterion for extreme disorder, which was
comparable with 75% of the proteins in hNuSP. In contrast,
only 49% of hSP and 42% of hNNuSP met our criterion for
extreme disorder. Thus, while nuclear autoantigens are no
more disordered than nuclear proteins as a whole, nuclear pro-
teins in general are significantly more likely to be disordered
than non-nuclear proteins. It is interesting to note that 50% of
the proteins annotated in SWISS-PROT as autoantigens are
nuclear proteins but only 21% of human proteins are nuclear,
implying disorder may play a role in this enrichment of nuclear
proteins as autoantigens.
Our results can be compared to a recent paper by Iakoucheva
et al. [22] that demonstrated that proteins associated with
cancer (79% of proteins) and proteins associated with signal
transduction (66% of proteins) are more highly disordered
than the typical eukaryotic protein in the SWISS-PROT data-
base (47% of proteins) or the PDB (13% of proteins). Note
that these authors have defined a long disordered region as
30 or more residues compared with our criterion of 39 or more
residues. Using Iakoucheva et al.'s criterion, we found that
83% of the proteins in hNuSysAAG met the requirement for
Figure 1
PONDR® predictions of disorder for four familiar human proteins. The SwissProt Accession Numbers [63] are given in parentheses. (a) Alpha-1-
antitrypsin (P01009); (b) hemoglobin B (P02023); (c) calmodulin (P62158); (d) transthyretin precursor human (P02766). The line at PONDR® 
score 0.5 defines the disorder threshold and is an arbitrary measure used to distinguish order from disorder. The PONDR® predictor used here and 
in all other diagrams in this paper is VL-XT, which is the default predictor on the PONDR® web site.
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are at least as disordered as the cancer-associated and sign-
aling proteins studied by Iakoucheva et al. [22].
Some additional evidence also suggests that disorder and
autoantigenicity are linked. In particular, the most common
autoantigens in the Sm particle are Sm B/B', Sm D1 and Sm
D3. All three proteins contain a long disordered region ≥39
consecutive residues. In contrast, a PONDR® analysis of Sm
E, Sm F, and Sm G, proteins in the Sm particle that are rarely
if ever autoantigens, lack long disordered regions (data not
shown).
Experimental evidence that nuclear systemic 
autoantigens are extremely disordered proteins
Certain experimental evidence suggests that most nuclear
systemic autoantigens are indeed, as predicted, disordered.
For example, the La autoantigen is known to be especially sen-
sitive to proteolysis consistent with a disordered structure
[23,24]. The amino terminus of DNA topoisomerase I has been
shown to be disordered by limited proteolysis [25], circular
dichroism and gel filtration [26]. Furthermore, the positively
charged tails of the histones are proteolytically sensitive and
are not observed to contribute electron density [27].
In general, it is difficult to crystallize extremely disordered pro-
teins. Thus X-ray studies of extremely disordered proteins tend
either to focus on the ordered domains of the proteins that can
be readily crystallized, or are studies of protein complexes
where some disordered domains become ordered on binding.
While NMR studies are not restricted to proteins that can crys-
tallize, only small proteins are readily amenable to NMR meth-
ods so that often only domains of larger proteins are studied.
Despite these limitations, direct evidence illustrated in Fig. 3
indicates that PONDR® predictions of disordered regions cor-
relate well with structural determinations for several nuclear
systemic autoantigens.
The fact that the structural studies in each of these cases stop
close to the predicted boundary between order and disorder
strongly suggests that the indicated regions have been cor-
rectly identified as disordered by PONDR®. Some of the dis-
parity between prediction and experiment may be explained by
complex formation. For example, in topoisomerase I, PONDR®
predicts disorder from 365–404 and 437–475 whereas
structures of topoisomerase I in complex with DNA show
these regions are ordered. These residues possibly act as link-
ers connecting domains of topoisomerase I that interact with
opposite sides of the DNA; they may be unstructured in the
apoprotein and become ordered upon binding DNA.
Properties of disordered proteins of relevance to the 
nature of autoantigens
The amino acid composition of disordered regions is distinct
from that of ordered regions [6]. Typically disordered regions
are deficient in Trp, Cys, Phe, Ile, Tyr, Val, Leu, and Asn. They
are enriched in Ala, Arg, Gly, Gln, Ser, Pro, Glu, and Lys. This
bias in amino acid composition is reflected in the fact that dis-
ordered regions typically have a strong net charge, which is
the first attribute of autoantigens mentioned by Plotz [1]. One
Figure 2
The PONDR® plot of several autoantigens selected from Table I (Additional file 1)1 (Additional file 1). The proteins shown are: (a) histone H1b (P10412); (b) U1 
RNP70K (P08621); (c) Ro 52K (P19474); (d) SmB/B (P14678). The heavy horizontal black bars indicate regions of 39 or more successive disor-
dered residues with a PONDR® score greater than the threshold of 0.5.
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disordered regions is that many strongly disordered regions
have very low sequence complexity as measured by Shan-
non's entropy [13], which can in turn lead to a preference for
repetitive surface elements, the second of Plotz's factors
thought to influence autoantigen structure. (However, not all
regions of low sequence complexity are disordered.) The low
sequence complexity of autoantigens is readily observed using
a Web-based tool such as the GlobPlot™ server [18].
Although statistics on the fraction of all proteins that contain
segments of low complexity are not readily available, we note
that of 24 low complexity regions found in 13 of the most com-
mon nuclear systemic autoantigens, all but two occur in
regions of disorder as determined by PONDR® (data not
shown).
Many functions have been ascribed to disordered proteins [7],
but one of the most prominent is binding to nucleic acid [7,10].
This is also a factor mentioned by Plotz as a third characteristic
of the structure of autoantigens. In addition, recent work [28]
shows that sites of phosphorylation are correlated with sites of
protein disorder. Because phosphorylation/dephosphorylation
are factors mentioned by Plotz as likely to be important in the
selection of autoantigens [1], this is one more piece of evi-
dence, albeit indirect, that disorder is apt to play a role in this
process. The fourth structural criterion characteristic of
autoantigens noted by Plotz (citing Dohlman et al. [2]), is the
predicted presence of a coiled coil. The mechanism by which
coiled coils may promote antigenicity is unclear, but Howard
et al. [29] showed that a region at the amino terminus of the
autoantigen histidyl-tRNA synthetase (which Coils [30] pre-
Figure 3
PONDR® predictions compared to experimental structural determinations for various autoantigens. (a) La autoantigen (Swiss-Prot: P05455). The 
shaded box above the plot (residues 231–325) is the region that Jacks et al. [64] determined to be ordered via NMR. The empty boxes (residues 
214–230 and residues 326–408) are regions determined to be unstructured or disordered. The inset (PDB: 1OWX; La222-334) shows the confor-
mational flexibility of disordered regions at the amino and carboxyl terminii of the La fragment. (b) DNA topoisomerase I (Swiss-Prot: P11387). The 
structure was determined by X-ray methods for a protein-DNA complex (PDB: 1EJ9) encompassing residues 203–765 of DNA topoisomerase I. 
Residues 634–713 (empty box) are missing and, therefore, disordered in the structure [65]. The lightly shaded box at the amino terminus is the 
region that was determined to be disordered in the references cited above. (c) Histone H3 (Swiss-Prot: P68431). The structure of chicken H3 in a 
histone octamer complex (PDB: 2HIO) was determined by X-ray methods for residues 1–135. Residues 1–42 are missing, presumably due to disor-
der [66]. (d) Sm D1 (Swiss-Prot: P62314). The structure of a protein complex between Sm D1 (residues 2–119) and Sm D2 was studied by X-ray 
methods (PDB: 1B34) [67]. Residues 82–119 from Sm D1 are missing from the structure.
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autoimmunity by activation of dendritic cells. When we exam-
ined our database of nuclear systemic autoantigens using the
Coils predictor, we found that coiled coils were present in
29% of our proteins whereas long disordered regions were
present in 76% of our proteins. (Dohlman et al. [2] report a
value of 36.7% coiled coils in their database of systemic
autoantigens compared to 8.7% in the SwissProt and 1.1% in
the PDB.) Thus, in agreement with Dohlman et al. [2] coiled
coils appear to be over-represented in our collection of nuclear
systemic autoantigens. Coiled coils are predicted roughly as
frequently in our autoantigens that have long disordered
regions as in the minority that do not. However, it is interesting
to note that the most frequently encountered nuclear systemic
autoantigens, such as the histones, the Sm proteins, and the
U1 and centromere binding proteins, are all completely devoid
of predicted coiled coils and are extremely disordered. (It
should be noted that Dohlman et al. [2] stated that U1
snRNP70K and CENB possessed coiled coils. However,
using an updated version of the Coils predictor that was una-
vailable to Dohlman et al., we found that these two predictions
were in error. When the predictions were run using additional
weighting of the amino acids appearing in positions 1 and 4 of
the heptad repeat, which helps to rule out false positives, we
were unable to confirm the putative coiled coils.)
In some cases, a region predicted by PONDR® to be disor-
dered overlaps with a region predicted by Coils to be a coiled
coil. An example is Ro 52K. Here the two disordered regions
are predicted to be 124–174 and 183–261; the predicted
coiled coils cover 128–165 and 189–234. Ottosson et al.
[31] present experimental evidence showing the peptide
200–239 'had a partly α-helical secondary structure with
major contribution of random coil,' that is, both the Coils and
the PONDR® predictor seemed to be partially correct. In sum-
mary, we have confirmed the results of Dohlman et al. [2] that
coiled coils seem to be common in autoantigens, but there is
currently no evidence that this conclusion conflicts with the
prediction that nuclear systemic autoantigens are disordered.
Disordered regions are predicted to make poor T cell 
antigens
B cells generally require T cell help to become activated and
secrete their antibody product. Although T cells are required
for the production of antinuclear autoantibodies in multiple ani-
mal models and probably also in humans, it has been notori-
ously difficult to isolate nuclear antigen-reactive T cells and to
explore their specificity and function. We examined the pre-
dicted ability of several nuclear systemic autoantigens to func-
tion as T cell epitopes (when presented by MHC class II
molecules) and asked if these sequences resided in areas of
disorder; we used the web server ProPred [20,32]. This site
implements the computer program TEPITOPE, which predicts
peptide sequences that offer promise as promiscuous T cell
epitopes [33]. The available evidence, though limited, sug-
gests that TEPITOPE predicts many sequences that are
experimentally verified T cell epitopes, although it also predicts
many sequences to be T cell epitopes that cannot be verified
as such [34-36]. This latter point is hardly surprising as
TEPITOPE's predictions are based solely on binding to MHC
II and do not attempt to model cellular compartmentalization of
the antigen and specific proteolysis of the protein. The most
extensive analysis [37] suggests that at least 50% of
TEPITOPES predictions are verifiable, although the data also
suggest that predictions for certain MHC alleles may be more
accurate than others. We wondered if disordered regions
might be particularly poor candidates for strong binding to
MHC II proteins and, therefore, unlikely to be T cell epitopes.
Representative results for several HLA-DR alleles are shown in
Fig. 4. If one compares the overall pattern of PONDR® predic-
tions from Fig. 2 with the T cell antigen prediction from Fig. 4,
one can see that the strongly disordered regions of the
PONDR® plots correspond to regions of the T cell epitope plot
in which only a very few even potential epitopes are located.
By a potential epitope we mean epitope represented by a peak
in the ProPred output without necessarily considering whether
that peak is above the threshold. In fact, the vast majority of the
potential epitopes illustrated in Fig. 4 are below threshold and,
therefore, would not be predicted to be epitopes. For reasons
of space we only show the results for four alleles and the four
autoantigens whose PONDR® plot was displayed in Fig. 2. For
example, for Histone H1b in Fig. 2a the PONDR® plot shows
strong disorder in the region from residues 1–51 and from
112–218. The former region in Fig. 4a is somewhat depleted
of potential T cell epitopes and the latter nearly devoid of
potential epitopes. For U1 RNP70K the PONDR® plot in Fig.
2b shows strong regions of disorder at residues 52–91, 162–
209, and 224–418. Although there still appear to be some
possible epitope candidates in the former two regions in Fig.
4b, the latter region is again nearly devoid of potential
epitopes. In the PONDR® plot of Fig. 2c, the disordered
regions of Ro 52K from 124–174 and 183–261 can readily
be seen to correspond to a slight diminution in the frequency
of prospective epitopes in Fig. 4c. While the effect here is far
less dramatic than in the case of the three other autoantigens
pictured, the degree of disorder seen in Fig. 2 for Ro 52K is
considerably less than for the other autoepitopes. Finally, the
strongly disordered region in Sm B/B' from residues 51–240
in Fig. 2d corresponds to a marked deficit of potential T cell
candidates in the same region in Fig. 4d compared to the
number of potential epitopes in the first 50 residues. An even
more dramatic demonstration of the correspondence of
regions of extreme disorder and a lack of potential T cell
epitopes will be discussed in Fig. 5. Taken together, these
data suggest that disordered regions, probably because of
their conformational flexibility, masking by nucleic acids and
other proteins and their proteolytic lability, make poor anti-
gens. Thus, both intuitions about what makes a good antigen
and the computational analysis of predicted MHC II T cell
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targeted to extremely disordered regions. Proteins with exten-
sive regions of disorder are thus likely to elicit poor T cell
responses. B cells reactive against these nuclear antigens are
unlikely to receive cognate help, and would be neither acti-
vated nor deleted. These clones thus represent a potential
source of autoreactive antibodies.
Autoantibodies recognize both ordered and disordered 
regions
Given that clones targeted to extremely disordered proteins
are a potential source of autoimmune antibodies, it is natural
to wonder if in fact one can subsequently detect autoantibod-
ies directed against the disordered regions. The obvious way
to explore this question is to compare epitope maps for some
common autoantigens with the maps of disordered regions
provided by PONDR®. This exercise is, however, more difficult
than it might seem. For example, Moutsopoulos et al. [38] have
reviewed the epitope mapping data for Ro 60 kD, Ro 52 kD,
and La 48 kD. It is apparent from their paper that different
groups using different techniques on different patient samples
have identified different linear epitopes and that, for many of
the autoantigens, most of the protein sequence has been iden-
tified as an autoepitope by one group or another. Nonetheless,
one can ask if disordered regions ever appear as
autoepitopes. The answer is a clear yes. For example, in Ro
52K multiple authors have located an autoepitope at residues
216–292. Much of this epitope overlaps with the predicted
strongly disordered region in Ro 52K from residues 183–261
(see Fig. 2c). Similarly, autoantigen La shows a predicted
strongly disordered region from residues 369–408, which is
another region targeted by autoantibodies. Many other B cell
epitopes to Sm B have been located largely at the carboxyl ter-
minus of the protein [39]. As is readily seen in Fig. 2d, this
region of the protein is predicted to be largely disordered. Fur-
thermore, linear epitope mapping may not be finding the most
relevant conformational epitopes. So while it is clear that many
epitopes on autoantigens are located in disordered regions of
Figure 4
T cell epitopes for several autoantigens predicted by the ProPred server. (a) histone H1b (Swiss-Prot: P10412). (b) U1 RNP70K (Swiss-Prot: 
P08621). (c) Ro 52K (Swiss-Prot: P19474). (d) Sm B/B' (Swiss-Prot: P14678). Only four alleles are shown for each protein for the HLA antigens 
(from the top down): DRB1_0101; DRB1_0102; DRB_0301; and DRB1_0305. The patterns for the remaining MHC II alleles follow the same gen-
eral trends. The black bars highlight the long disordered regions of the sequence as pictured in Fig. 2. The horizontal dotted red line is the threshold 
score-here set at the default value of 3%, which is used to differentiate between binders and non-binders. A threshold of 3% means that the protein 
sequence belongs to the 3% best scoring natural peptides. The lower the threshold percentage the fewer false positive peptides will be predicted to 
be T cell epitopes.
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often autoepitopes, rendering any correspondence between
disordered regions and autoepitopes less than convincing.
Protein disorder and epitope spreading
Spreading describes the extension of immune reactivity from
an initial region of strong antigenicity towards a polypeptide
into other epitopes of the autoantigen, or even from an epitope
in one polypeptide to another polypeptide in a macromolecular
complex such as the nucleosome or the Sm particle [40,41].
Spreading can lead to a more rapid and intense secondary
response, longer lasting immune memory and multiple other
advantages [40]. In a disease such as SLE, the reactivity can
even extend into a different type of macromolecule such as
DNA or RNA. Judith James and her colleagues have carried
out several elegant experimental demonstrations of spreading.
In a key study [42] they showed that immunization of rabbits
with the peptide PPPGMRPP, a repeated sequence within the
carboxyl terminus of Sm B/B', led to a spreading of the B cell
response to many different structures on the SmB/B' autoan-
tigen. A salient observation was that the antibodies reactive
against these secondary determinants were in general not
cross-reactive with the initiating peptide. In subsequent work
[43], these authors showed that the closely related peptide
Figure 5
Disorder and T cell epitope prediction for EBV Nuclear Antigen 1. (a) PONDR® plot of the Epstein Barr Nuclear Antigen 1 protein (Swiss-Prot: 
P03211). The PPPGRPP epitope that induces cross-reactivity to an epitope on Sm B/B' is found in residues 398–412, almost exactly at the sharp 
minimum of the PONDR® plot. This is the only known cross-reacting epitope in the virus. (b) T cell epitopes of EBNA1 predicted by the ProPred 
server. Only the results for alleles HLA-DRB_01, HLA-DRB_0102, HLA-DRB1_0301, and HLA-DRB_0305 are shown. The remaining 47 alleles 
show a very similar picture. The threshold is set at 3%. The black bars delimit the strongly disordered regions of the PONDR® plot shown in (a). It is 
apparent that the highly disordered region of the first approximately 400 amino acids is predicted to be nearly devoid of potential T cell epitopes. The 
epitope from residues 398–412 that cross-reacts with the SmB protein is predicted to be most reactive with alleles HLA DRB5_0101 and 
DRB5_0105, although just slightly below a 3% threshold (data not shown).
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R1368PPPGRPP found in the nuclear antigen 1 (EBNA1) of the
Epstein-Barr virus (EBV) was also capable of eliciting a lupus-
like disease in rabbits. This result is of great interest given the
evidence that the authors cite that EBV may be an etiological
agent of autoimmune disease. A reasonable hypothesis is thus
that EBV might attempt to circumvent immune surveillance by
utilizing molecular mimicry. The subsequent attempt to deal
with an EBV infection might lead to an autoimmune attack, ini-
tially on similar sequences in the B/B' polypeptide followed by
spreading to the rest of the Sm particle.
To further explore the relevance of disorder to the idea of
spreading we carried out a PONDR® analysis of the EBNA1
protein. The results are shown in Fig. 5. The results shown in
Fig. 5a extend the notion of molecular mimicry [44] by sug-
gesting that the EBNA1 protein has evolved to present, as
nearly as possible, a disordered face to the immune system.
The PPPGRPP epitope is one of the few regions of the protein
that is relatively ordered, and because it mimics a self-antigen
of Sm B/B' the immune system has a difficult job in defending
against EBV infection. An antibody response against the
ordered epitope risks subsequent development of autoim-
mune disease because the same spreading, which presuma-
bly allows defense against the disordered regions of EBNA1,
carries the risk of a similar spreading to other epitopes in the
Sm particle.
This view of the battle between the virus and the immune sys-
tem is further amplified by the results of the analysis of MHC II
T cell epitopes using the ProPred server shown in Fig. 5b.
Here we can see that the extremely disordered regions of the
virus contain essentially no predicted T cell epitopes in the
context of MHC II. This is further strong evidence that a sus-
pected pathogen implicated in autoimmune disease has
escaped immune surveillance by using disorder to 'fly below'
the level of sensitivity of the T cell receptor. Thus the virus
seems to use both disorder and molecular mimicry as part of
the infectious process. There have been earlier suggestions
that protein disorder may allow viruses or presumably other
pathogens to evade immune detection [45,46]. While the
above example supports the notion of molecular mimicry as an
important process in the development of autoimmune disease,
we do not wish to suggest that other mechanisms that might
lead to autoimmunity have been ruled out. Indeed, it seems
that defects in apoptosis allowing exposure of cryptic disor-
dered antigens to the immune system might be an important
mechanism in many cases [12,47,48].
As another example of how a consideration of protein disorder
can shed light on the phenomenon of spreading we consider
further work from James' group [49]. They examined the
immunogenicity and antigenicity in rabbits of two strong
epitopes of the lupus autoantigen small nuclear ribonucleopro-
tein particle U1 snRNPA protein (also known as the U1A pro-
tein). One peptide, A3, was a strong immunogen, and in the
months following initial immunization antibodies against this
peptide exhibited spreading to other common epitopes of U1
snRNPA. In contrast, the A6 peptide was a weaker immuno-
gen, and antibodies to this epitope do not show spreading.
Not only was spreading associated solely with the A3 epitope,
but also this epitope, unlike the A6 epitope, was able to induce
clinical signs of autoimmune disease such as leukopenia and
renal insufficiency. The authors asked why these two epitopes,
located fairly close together in the same polypeptide, exhibit
such different immunological and pathological properties.
They point out that the two peptides have similar high isoelec-
tric points, which are fair indicators of antigenicity in the
snRNP system, and that A6, like some other autoimmune
epitopes, is relatively non-immunogenic. It may be significant
that, as shown in the PONDR® plot in Fig. 6, the A3 epitope
that is capable of inducing spreading and autoimmune disease
like the EBNA1 epitope shown in Fig. 5, is in a strongly
ordered region located adjacent to regions of strong disorder
of the PONDR® plot. In contrast, the A6 epitope is in a region
of strong disorder. Once again in support of these notions, we
have carried out an analysis of the predicted T cell epitopes in
these regions. The results shown in Fig. 6b confirm a paucity
of T cell MHC II epitopes in the extremely disordered region
96–226. In particular, there are few even potential T cell
epitopes predicted in the region from 103–115 where the A6
peptide is located.
Recent work on the mechanism of spreading from Gordon,
McCluskey and colleagues [50] extending their earlier studies
of the Ro/La system [51,52] suggest that one can obtain an
antibody response to several regions of the La autoantigen fol-
lowing immunization with recombinant La. In contrast, when
they immunized with Ro 52K or Ro 60K, the only region of La
in which spreading was seen to occur was the carboxy-termi-
nal region which, as shown in Fig. 3a, is the only region of La
that is strongly disordered. These results are again consistent
with the pattern of spreading moving from ordered to disor-
dered regions.
Discussion
Any theory of autoimmunity needs to account for at least two
observations. The first is of the existence of large numbers of
self-reactive immune cells, normally deleted or inactivated dur-
ing tolerization, with specificity for a limited number of autoan-
tigens. The second is that having escaped destruction, these
immune cells can somehow subsequently become activated.
The appreciation that many nuclear autoantigens are
disordered can shed light on possible mechanisms by which
both of these events can occur.
A priori one might expect the disordered regions of proteins to
be poor antigens. By definition they exist in multiple conforma-
tions, which would suggest that it would be difficult to develop
a conformation-specific antibody against such a region. In
addition, disordered regions are very sensitive to proteolysis
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R1369[7]. Furthermore, because disordered regions are often bound
to other proteins or to nucleic acids, they may be masked and
physically unavailable to the immune system [49]. Finally, as
shown by the ProPred analysis, disordered regions are only
rarely apt to be T cell epitopes. In summary, the recognition
that most nuclear systemic autoantigens contain long
disordered regions goes a long way towards explaining why a
pool of potentially autoreactive B cells, of very low affinity that
are targeted largely towards disordered regions, persists even
in healthy individuals.
However, the very success of the concept of autoantigen dis-
order in explaining the persistence of B cells directed to self-
epitopes only intensifies the difficulty of understanding how
disordered regions could ever become the targets of autoim-
mune attack. Having argued that disordered regions are
largely invisible to both T and B cells, how can we explain why
in a few percent of individuals this invisibility is breached and
autoimmune disease ensues? We agree with earlier authors
that the key event is likely to be spreading. Although the data
presented support the notion that spreading initiates at
ordered epitopes and can spread through disordered regions
to elicit autoimmune disease, we have said little about how this
might occur. What exactly is the role of the ordered epitope in
initiating spreading, and how might it contribute to the activa-
tion of the pool of self-reactive progenitor B cells potentially
targeted to disordered regions? We suggest that a key to this
process lies in the large size, high level of expression, and
Figure 6
Disorder and T cell epitope for U1 snRNPA. (a) PONDR® plot of the U1 snRNPA protein (Swiss-Prot: P09012). The location of the strongly immu-
nogenic peptide A3 (residues 44–56), which induces spreading and systemic autoimmune disease, is indicated by XXX. The weakly immunogenic 
peptide A6 (residues 103–115), which does not induce spreading or autoimmune disease [49], is indicated by xxx. (b) ProPred analysis of the U1 
snRNPA protein in the context of MHC II. Only the results for alleles HLA-DRB_01, HLA-DRB_0102, HLA-DRB1_0301, and HLA-DRB_0305 are 
shown. The remaining 47 alleles show a very similar picture. The threshold is set at 3%. The black bar delimits the long disordered region of (a).
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and in particular the fact that frequently these autoantigens are
part of structural macromolecular complexes. The model is
diagrammed in Fig. 7.
In Fig. 7 the 'primary' progenitor B cell displaying the autore-
active surface Ig (sIg) binds to and processes the determinant
and displays the resulting epitopes to T cells in the context of
MHC II and accessory proteins in a typical immune synapse.
Figure 7
A scaffolding model for antigen spreading. Shown is the target of an autoimmune response; here a snRNP particle that expresses at least two anti-
genic determinants. The determinant represented by the rectangle, which might be for example the PPPGRRP sequence on EBNA1, is assumed to 
cross react with the determinant PPPGMRPP on the snRNP via a conventional immune synapse. We denote progenitor B cells participating in these 
cognate interactions with T cells as primary progenitor B cells. Also shown is a second determinant on the small nuclear ribonucleoprotein particle 
(snRNP; represented by a circle) that is assumed to be more strongly disordered than the rectangular determinant. Progenitor B cells reacting with 
this determinant, termed secondary progenitor B cells, are capable of spreading the immune response via an eavesdropping mechanism as dis-
cussed in the text. EBV, Epstein-Barr virus.
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R1371We designate this sort of T cell cytokine activation of progen-
itor B cells 'cis' activation to indicate that the activation is to a
progenitor B cell displaying sIg directly in close proximity to a
T cell bearing a homologous T cell receptor via a conventional
cognate cell to cell immune synapse.
In our view, the 'secondary' B progenitor cell in Fig. 7 becomes
activated via a rather different mechanism. B cell progenitors
capable of efficient, high-affinity binding to disordered deter-
minants are few. Instead, there are many B cells that bind with
low affinity to these determinants, a binding which is insuffi-
cient for their deletion or inactivation. The result is the persist-
ence of large numbers of B cells reactive to disordered
determinants on proteins. Furthermore, due to the proteolytic
lability of strongly disordered peptides, peptides derived from
disordered regions cannot be efficiently presented in the con-
text of MHC II, as suggested by the gaps in the T cell epitope
profile for disordered regions shown in Figs 4, 5, 6. Thus, it is
difficult to present peptides derived from disordered regions in
a conventional immune synapse. However, if a second snRNP
should bind to a cross reactive B cell progenitor via its own
sIg, a 'secondary' B cell progenitor with sIg that binds (weakly)
to the circular epitope can be brought into close proximity of
the activated T cell, such that cytokines from this T cell, which
can act only over short distances, can act in 'trans' to activate
the secondary B progenitor cell. This secondary B cell progen-
itor is thus activated by 'eavesdropping' on the signals being
sent from the T cell to the primary B progenitor cell. In this
model, the snRNP acts as a molecular scaffold to bring the
two B progenitor cells into close proximity of the T cell to allow
cytokine eavesdropping.
The model outlined in Fig. 7 bears some resemblance to other
published models of spreading [53,54] but it differs in several
notable aspects. Fatenejad and Craft [51] propose two mod-
els for spreading. In both models, a T cell is able to activate B
cells with different specificities, but all the T/B interactions
proceed via a conventional immune synapse. This is also the
case for the model of Deshmukh et al. [52]. The weakness of
all these models is that they presuppose secondary B cells
binding to and processing secondary antigens in the absence
of T cell help. Yet if this process occurred with any frequency,
one would expect that such B cells would be activated and
subject to immune deletion. The key difference between our
model and those proposed is that we do not require such
processing by potentially autoimmune B cell precursors
because the secondary B cell precursors use 'eavesdropping'
to obviate the need for conventional T/B immune synapses.
Our model makes several predictions about the nature of the
T and B cells that participate in autoimmune disease. Some of
these predictions are characteristic of a wide range of models
of autoimmunity and are, therefore, not terribly informative in
deciding for or against the model. Still, it is important to note
that the model is consistent with a great deal of information
that is available about autoimmunity, for example, that autoim-
mune B cell populations are clonal, that the diseases are anti-
gen driven, that the presence of an autoreactive B cell
receptor is insufficient in itself to drive that cell into an autoim-
mune response, that there is no global defect in B cell elimina-
tion in autoimmunity and that helper T cells are required for
autoimmune disease [55].
More telling are some less obvious predictions. The first of
these is that only T cells with a very limited range of specifici-
ties are needed to activate secondary B cells carrying a wide
range of specificities. The study of T-cell clones specific for
several autoantigens of snRNPs strongly supports this predic-
tion [56]. The model also predicts that soluble factors alone
are insufficient to drive autoantibody production, and that
some of the interactions in systemic autoimmunity are MHC II
restricted [57].
Another prediction of the model is that one might find associ-
ated with the MHC II protein of secondary B cells peptides
that would normally not have access to the MHC II pathway.
This breakdown of pathway specificity might occur because
there is no T cell synapse to ensure that only class II peptides
are presented by the secondary B cells. Such a breakdown in
pathway specificity has been experimentally observed [58].
Another prediction is that autoimmunity should be a relatively
rare phenomenon on a per cell basis [59]. The model presup-
poses a syzygy of three immune cells linked via an autoantigen
scaffolding. It seems likely that this is a relatively rare event
compared to a normal T/B interaction of two cells, but made
more likely for highly expressed proteins. The recent observa-
tion by Greidinger et al. [60] that direct T cell contact with B
cells is not needed for T cell help in autoimmunity is also in
striking agreement with our model.
Perhaps the most dramatic prediction of the model is that the
T cell epitopes associated with autoimmunity should most
frequently be derived from ordered regions of autoantigens
because such regions can engage in conventional immune
synapses. Talken et al. [61] have presented evidence support-
ing this prediction. They identified a series of peptides derived
from SmB capable of stimulating T cell clones isolated from
patients with SLE. They identified only three T cell epitopes
from a total of seven patients. Of these peptides, a single pep-
tide denoted as SmB-E1 comprising residues 16–33 of the
SmB sequence was by far the most frequently encountered.
This peptide was able to promote the growth of 23 out of 54
total T cell clones. Clones responsive to this peptide were
present in five out of the seven patients. Considering that only
a single clone was derived from two patients, it is apparent
that this epitope is by far the most frequently encountered T
cell epitope directed against SmB. A longitudinal analysis
showed that response to this epitope remained stable for the
two years of the study. Strikingly, this peptide (residues 16–
33) is derived from the few residues (17%) in SmB that are
predicted to be ordered (Fig. 2d) as predicted by the scaffold-
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additional evidence supporting this prediction (data not
shown).
Conclusion
Nuclear autoantigens exhibit a remarkable degree of disorder.
This property may explain the singular skewing of
autoantibodies toward these nuclear proteins. We present a
framework for considering how protein disorder might lead to
autoreactivity. Our scheme unites the notions of tolerance,
molecular mimicry, spreading and nucleic acid or protein bind-
ing by autoantigens into a coherent whole, but is conservative
in that except for introducing the notion of disorder it does not
posit any novel attributes of pathogens, the immune system,
protein structure or autoantigens that have not been sug-
gested in the past. There are preliminary suggestions that dis-
order may contribute to the development of autoantigens in
the cytoplasm, such as the 60S acidic ribosomal proteins and
golgins, and in some types of organ specific disease, such as
multiple sclerosis (myelin basic protein), and celiac disease
(tissue transglutaminase). Whatever the exact details that
emerge from further analysis, we suggest that there is reason
to suppose that protein order/disorder has a part to play in
explaining the Wunderkammer of autoantigens.
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